Document is current
Any future updates will be listed below
-
Authors
Guadagni, Stefano
Fiorentini, Giammaria
Papasotiriou, Ioannis
Apostolou, Panagiotis
Masedu, Francesco
Sarti, Donatella
Farina, Antonietta Rossella
Mackay, Andrew Reay
Clementi, Marco
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01920516 at ClinicalTrials.govDocuments that mention this clinical trial
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study
https://doi.org/10.1186/s13104-020-05021-5
Surgical versus percutaneous isolated pelvic perfusion (IPP) for advanced melanoma: comparison in terms of melphalan pharmacokinetic pelvic bio-availability
https://doi.org/10.1186/s13104-017-2738-y
- License Information
-
More Information
Article History
Received: 18 February 2020
Accepted: 13 March 2020
First Online: 24 March 2020
Ethics approval and consent to participate
: This project has been performed in accordance with the Declaration of Helsinki and has been approved by the ethics committee of ASL n.1, Abruzzo, Italy (Chairperson: G. Piccioli; protocol number 10/CE/2018; date of approval: 19 July, 2018 (n. 1419), L’Aquila, Italy). Written informed consent was obtained from each of the 7 patients.
: The manuscript does not contain any individual person data, so consent for publication is not applicable.
: The authors declare that they have no competing interests.
